LiliumX

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

VelaVigo

This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

BiVictrix Therapeutics Plc

The company develops selective antibody-drug conjugates for the treatment of various cancers, including liquid and solid tumours, for the pharmaceutical and clinical sectors.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.